NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | Teva Pharmaceuticals, Inc. | 826fd9e3-22fe-408b-820c-f2b710189555 | 2024-12-01 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Sudafed Sinus 12 Hour Pressure plus Pain | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | Kenvue Brands LLC | 305adca3-cdae-41e5-a10a-99d9dd0fe390 | 2024-11-08 | Warnings | 9TN87S3A3C |
| Caladryl | FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE | Bausch Health US, LLC | 67d4fd42-9fed-4238-9f5a-c9403abbcf20 | 2024-10-17 | Warnings | 1K09F3G675 |
| Belmora Flanax | NAPROXEN SODIUM | Belmora LLC | a44b8a82-251d-d5e8-e053-2a95a90a72f7 | 2024-10-08 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | Albertsons Companies | f9df7495-9da7-8838-e053-6294a90a6fda | 2024-09-30 | Warnings | 9TN87S3A3C |
| Calamine | CALAMINE AND ZINC OXIDE | Strategic Sourcing Services, LLC | 22173332-9d09-768c-e063-6394a90a94e1 | 2024-09-14 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | da61463f-f87b-4aba-b538-7264252cadb8 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198013 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 1fe9a6fc-940e-4a18-b3e9-b204fd67f263 | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 205b1159-06e5-0d48-e063-6294a90acbd8 | 2024-08-23 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | a4f31070-4ee1-4d64-8b1d-40b9011e124b | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | NuCare Pharmaceuticals,Inc. | 5e873524-f9fb-fe2d-e053-2991aa0aa0a5 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | NuCare Pharmaceuticals, Inc. | 46dd3908-6feb-4f50-e054-00144ff88e88 | 2024-08-14 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | NuCare Pharmaceuticals, Inc. | 3e8bcc59-dab1-1b4c-e054-00144ff88e88 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198014 57Y76R9ATQ |
| Naproxen sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 42f6a3a0-5a1e-40ca-8949-b8870dd95d2e | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 849431 9TN87S3A3C |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 5487dee2-5c37-4348-e054-00144ff8d46c | 2024-07-17 | Warnings | 198014 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | Alvogen Inc. | 9225acaa-209f-958b-2c51-9a46995dec33 | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Naprelan | NAPROXEN SODIUM | Almatica Pharma LLC | e633ff0b-eab7-f167-8d08-e9236e54042b | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 9TN87S3A3C |
| Artificial Tears | POLYVINYL ALCOHOL, POVIDONE | NuCare Pharmaceuticals,Inc. | 9c1c4911-908e-3c3c-e053-2995a90abcfc | 2024-06-14 | Warnings | FZ989GH94E |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 71d4a048-ca50-73db-e053-2a95a90ad465 | 2024-06-10 | Warnings | 198013 57Y76R9ATQ |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 69366b55-2687-17a4-e053-2a91aa0a65b3 | 2024-06-07 | 198014 57Y76R9ATQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.